• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米颗粒的白消安免疫分析法在常规临床分析仪上的快速分析评价。

Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers.

机构信息

Saladax Biomedical, Inc., Bethlehem.

Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.

出版信息

Ther Drug Monit. 2021 Dec 1;43(6):766-771. doi: 10.1097/FTD.0000000000000883.

DOI:10.1097/FTD.0000000000000883
PMID:33814542
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8594508/
Abstract

BACKGROUND

Busulfan is an alkylating agent used in allogeneic hematopoietic stem cell transplantation for various malignant and nonmalignant disorders. Therapeutic drug monitoring of busulfan is common because busulfan exposure has been linked to veno-occlusive disease, disease relapse, and failed engraftment. The authors developed an automated immunoassay, along with stable calibrators and controls, and quantified busulfan in sodium heparin plasma.

METHODS

The authors evaluated a homogenous nanoparticle immunoassay, the MyCare Oncology Busulfan Assay Kit (Saladax Biomedical, Inc), for precision, sensitivity, accuracy, and linearity on an open channel clinical chemistry analyzer; they compared the method with 2 mass spectrometry methods (liquid chromatography-tandem mass spectrometry and gas chromatography/mass spectrometry), using anonymized, remnant patient samples.

RESULTS

The coefficients of variation for repeatability and within-laboratory precision were ≤9.0%. The linear range was 150-2000 ng/mL; samples up to 6000 ng/mL can be measured with sample dilution. Measured values deviated by ≤14% from assigned values. Comparison between validated mass spectrometry methods resulted in a correlation coefficient R ≥ 0.995.

CONCLUSIONS

The MyCare Busulfan Assay Kit shows the precision, accuracy, linearity, and test range for performing busulfan concentration measurements in sodium heparin plasma on routine clinical chemistry analyzers.

摘要

背景

白消安是一种烷化剂,用于治疗各种恶性和非恶性疾病的异基因造血干细胞移植。由于白消安的暴露与静脉阻塞性疾病、疾病复发和植入失败有关,因此对白消安进行治疗药物监测很常见。作者开发了一种自动化免疫分析法,同时还开发了稳定的校准品和对照品,并对肝素钠血浆中的白消安进行定量。

方法

作者评估了一种均质纳米颗粒免疫分析法,即 MyCare Oncology Busulfan 检测试剂盒(Saladax Biomedical,Inc.),用于在开放通道临床化学分析仪上评估其精密度、灵敏度、准确性和线性度;他们使用匿名的剩余患者样本,将该方法与 2 种质谱方法(液相色谱-串联质谱法和气相色谱/质谱法)进行了比较。

结果

重复性和实验室内精密度的变异系数均≤9.0%。线性范围为 150-2000ng/mL;可以通过样品稀释测量高达 6000ng/mL 的样品。测量值与赋值值的偏差≤14%。验证后的质谱方法之间的比较得出相关系数 R≥0.995。

结论

MyCare Busulfan 检测试剂盒在常规临床化学分析仪上用于测量肝素钠血浆中的白消安浓度时,显示出精密度、准确性、线性度和测试范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/bb6adcecfe8b/tdm-43-766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/3f11864e4274/tdm-43-766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/a1d94b929cd4/tdm-43-766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/a221a7411970/tdm-43-766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/f9347e12b48c/tdm-43-766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/bb6adcecfe8b/tdm-43-766-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/3f11864e4274/tdm-43-766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/a1d94b929cd4/tdm-43-766-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/a221a7411970/tdm-43-766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/f9347e12b48c/tdm-43-766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/8594508/bb6adcecfe8b/tdm-43-766-g005.jpg

相似文献

1
Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers.基于纳米颗粒的白消安免疫分析法在常规临床分析仪上的快速分析评价。
Ther Drug Monit. 2021 Dec 1;43(6):766-771. doi: 10.1097/FTD.0000000000000883.
2
Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers.全自动监测白消安治疗药物浓度:两种常规化学分析仪上免疫分析法的评估。
Ther Drug Monit. 2022 Apr 1;44(2):335-339. doi: 10.1097/FTD.0000000000000933.
3
Evaluation of Busulfan as a Third-Party Immunoassay on a Clinical Chemistry Analyzer.白消安作为临床化学分析仪上的第三方免疫分析方法的评估。
J Appl Lab Med. 2024 May 2;9(3):549-557. doi: 10.1093/jalm/jfad134.
4
Development and evaluation of a nanoparticle-based immunoassay for determining paclitaxel concentrations on routine clinical analyzers.基于纳米粒子的免疫分析法的开发和评估,用于在常规临床分析仪上测定紫杉醇浓度。
Ther Drug Monit. 2013 Dec;35(6):809-15. doi: 10.1097/FTD.0b013e318296be01.
5
Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfan.一种用于定量血浆白消安的液相色谱-串联质谱分析方法的开发与验证
Ther Drug Monit. 2014 Apr;36(2):169-74. doi: 10.1097/01.ftd.0000443060.22620.cd.
6
An automated nanoparticle-based homogeneous immunoassay for determining docetaxel concentrations in plasma.基于纳米颗粒的自动化均相免疫分析法测定血浆中多西他赛浓度。
Ther Drug Monit. 2013 Dec;35(6):803-8. doi: 10.1097/FTD.0b013e31829617ea.
7
Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.用于治疗药物监测的血浆中吉西他滨定量快速均相免疫测定法。
Ther Drug Monit. 2017 Jun;39(3):235-242. doi: 10.1097/FTD.0000000000000402.
8
High-Throughput Validated Method for the Quantitation of Busulfan in Plasma Using Ultrafast SPE-MS/MS.使用超快速固相萃取-串联质谱法定量血浆中白消安的高通量验证方法。
Ther Drug Monit. 2015 Jun;37(3):319-24. doi: 10.1097/FTD.0000000000000159.
9
Quantification of human plasma-busulfan concentration by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法对人血浆中环磷酰胺浓度进行定量分析。
Ann Lab Med. 2014 Jan;34(1):7-14. doi: 10.3343/alm.2014.34.1.7. Epub 2013 Dec 6.
10
A Simple and Accurate Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Busulfan in Plasma.一种用于血浆中白消安治疗药物监测的简单准确的液相色谱-串联质谱法。
Ann Clin Lab Sci. 2019 Mar;49(2):212-217.

引用本文的文献

1
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT).白消安治疗药物监测实用指南:欧洲血液与骨髓移植学会(EBMT)药剂师委员会的建议
Bone Marrow Transplant. 2024 Dec;59(12):1641-1653. doi: 10.1038/s41409-024-02413-0. Epub 2024 Sep 13.
2
Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Plasma Busulfan.液相色谱-串联质谱法测定血浆中白消安的浓度
Methods Mol Biol. 2024;2737:133-140. doi: 10.1007/978-1-0716-3541-4_13.
3
Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices.
细胞毒性抗癌药物的治疗药物监测:原则与循证实践
Front Oncol. 2022 Dec 8;12:1015200. doi: 10.3389/fonc.2022.1015200. eCollection 2022.